Process Control

Is there data demonstrating significant cost benefits from continuous biomanufacturing?

We interview Johannes Khinast, CEO and Scientific Director of the Research Center for Pharmaceutical Engineering (RCPE), Graz, Austria.

How can companies avoid the risks of HPAPI containment and handling?

Amgen has brought the Multi-Attribute Method (MAM) into the mainstream, but what’s next for this analytical workflow. Click to read article

Amgen developed the Multi-Attribute Method (MAM) to obtain high-fidelity understanding of the quality of its own biologics. Click to read article

We speak with Richard Bourne about his work on pharmaceutical processes.

We’re moving towards a data-driven future of enhanced manufacturing. And we must lay the foundations today.

Guia Bertuzzi, Product Manager for Granulation at IMA Active, Italy, discusses the evolution of granulation machinery.

Bernhardt Trout talks about the ways in which continuous manufacturing can meet the needs of the ever-changing pharmaceutical industry.

How are reactor technologies supporting pharma companies?